Abstract
Patients with hilar cholangiocarcinoma require anesthesia for a number of surgical procedures. This ranges from minimally invasive surgery, such as diagnostic laparoscopy, to major procedures including liver transplantation. Anesthetic management in these patients is not only dependent on the magnitude of surgery, but also on any concurrent illnesses. In this chapter, we outlined the principles of anesthesia and perioperative management for patients with hilar cholangiocarcinoma undergoing a variety of surgery.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Zografos GN, Farfaras A, Zagouri F, et al. Cholangiocarcinoma: principles and current trends. Hepatobiliary Pancreat Dis Int. 2011;10:10–20.
Regimbeau JM, Fuks D, Le Treut YP, et al. Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group. J Gastrointest Surg. 2011;15:480–8.
Cai WK, Sima H, Chen BD, et al. Risk factors for hilar cholangiocarcinoma: a case-control study in China. World J Gastroenterol. 2011;17:249–53.
Ito F, Cho CS, Rikkers LF, et al. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250:210–8.
Chamberlain RS, Blumgart LH. Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol. 2000;7:55–66.
de Martel C, Plummer M, Franceschi S. Cholangiocarcinoma: descriptive epidemiology and risk factors. Gastroenterol Clin Biol. 2010;34:173–80.
Jonas S, Benckert C, Thelen A, et al. Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol. 2008;34:263–71.
Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin North Am. 2000;14:521–46.
Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol. 2009;6:533–41.
Squizzato A, Keller T, Romualdi E, et al. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane Database Syst Rev. 2011;19(1):CD005158.
Pulmonary Embolism Prevention (PEP) trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355:1295–302.
Levy JH, Azran M. Anesthetic concerns for patients with coagulopathy. Curr Opin Anaesthesiol. 2010;23:400–5.
Bradlow BA, Chetty N. Dosage frequency for suppression of platelet function by low dose aspirin therapy. Thromb Res. 1982;27:99–110.
Patrono C, Ciabattoni G, Patrignani P, et al. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation. 1985;72:1177–84.
Cheng B, Hung CT, Chiu W. Herbal medicine and anaesthesia. Hong Kong Med J. 2002;8:123–30.
Child CG. The liver and portal hypertension. Philadelphia: Saunders; 1964.
Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9.
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–70.
Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652–60.
Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl. 2007;13:1174–80.
Huo TI, Wang YW, Yang YY, et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int. 2007;27:498–506.
Sakka SG. Assessing liver function. Curr Opin Crit Care. 2007;13:207–14.
Fazakas J, Mándli T, Ther G, et al. Evaluation of liver function for hepatic resection. Transplant Proc. 2006;38:798–800.
Morris-Stiff G, Gomez D, Prasad R. Quantitative assessment of hepatic function and its relevance to the liver surgeon. J Gastrointest Surg. 2009;13:374–85.
Seibel A, Müller A, Sakka SG. Indocyanine green plasma disappearance rate for monitoring hepatosplanchnic blood flow. Intensive Care Med. 2011;37:357–9.
Reekers M, Simon MJ, Boer F, et al. Pulse dye densitometry and indocyanine green plasma disappearance in ASA physical statusI-II patients. Anesth Analg. 2010;110:466–72.
Fan ST. Liver functional reserve estimation: state of the art and relevance for local treatments: the eastern perspective. J Hepatobiliary Pancreat Sci. 2010;17:380–4.
Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355–73.
Mann DV, Lam WW, Hjelm NM, et al. Metabolic control patterns in acute phase and regenerating human liver determined in vivo by 31-phosphorus magnetic resonance spectroscopy. Ann Surg. 2002;235:408–16.
Wakamatsu H, Nagamachi S, Kiyohara S, et al. Predictive value of Tc-99m galactosyl human serum albumin liver SPECT on the assessment of functional recovery after partial hepatectomy: a comparison with CT volumetry. Ann Nucl Med. 2010;24:729–34.
Manizate F, Hiotis SP, Labow D, et al. Liver functional reserve estimation: state of the art and relevance to local treatments. Oncology. 2010;78 Suppl 1Suppl 1:131–4.
Jakob SM. Splanchnic blood flow in low-flow states. Anesth Analg. 2003;96:1129–38.
Groszmann RJ, Abraldes JG. Portal hypertension: from bedside to bench. J Clin Gastroenterol. 2005;39(4 Suppl 2):S125–30.
Asfar P, De Backer D, Meier-Hellmann A, et al. Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock. Crit Care. 2004;8:170–9.
Vedrinne JM, Duperret S, Bizollon T, et al. Comparison of transesophageal and transthoracic contrast echocardiography for detection of an intrapulmonary shunt in liver disease. Chest. 1997;111:1236–40.
Williams RL. Drug administration in hepatic disease. N Engl J Med. 1983;309:1616–22.
Rodighiero V. Effects of liver disease on pharmacokinetics. An update. Clin Pharmacokinet. 1999;37:399–431.
Wood M. Plasma drug binding: implications for anesthesiologists. Anesth Analg. 1986;65:786–804.
Stoelting RK, Hiller AC. Pharmacology and physiology in anesthetic practice. Philadelphia: Lippincott Williams and Wilkins; 2006.
Merritt WT. Perioperative concerns in acute liver failure. Int Anesthesiol Clin. 2006;44:37–57.
Reichle FM, Conzen PF. Halogenated inhalational anaesthetics. Best Pract Res Clin Anaesthesiol. 2003;17:29–46.
Sinha A, Clatch RJ, Stuck G, et al. Isoflurane hepatotoxicity: a case report and review of the literature. Am J Gastroenterol. 1996;91:2406–9.
Singhal S, Gray T, Guzman G, et al. Sevoflurane hepatotoxicity: a case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther. 2010;17:219–22.
Berghaus TM, Baron A, Geier A, et al. Hepatotoxicity following desflurane anesthesia. Hepatology. 1999;29:613–4.
Myles PS, Leslie K, Silbert B, et al. A review of the risks and benefits of nitrous oxide in current anaesthetic practice. Anaesth Intensive Care. 2004;32:165–72.
Myles PS, Leslie K, Chan MTV, ENIGMA Trial Group, et al. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology. 2007;107:221–31.
Leslie K, Myles PS, Chan MTV, et al. Risk factors for severe post-operative nausea and vomiting in a randomised trial of nitrous oxide-based versus nitrous oxide-free anaesthesia. Br J Anaesth. 2008;101:498–505.
Myles PS, Chan MTV, Leslie K, et al. Effect of nitrous oxide on plasma homocysteine and folate in patients undergoing major surgery. Br J Anaesth. 2008;100:780–6.
Graham AM, Myles PS, Leslie K, et al. A cost-benefit analysis of the ENIGMA trial. Anesthesiology. 2011;115:265–72.
Myles PS, Chan MTV, Kaye DM, et al. Effect of nitrous oxide anesthesia on plasma homocyst(e)ine and endothelial dysfunction. Anesthesiology. 2008;109:657–63.
Myles PS, Leslie K, Peyton P, ANZCA Trials Group, et al. Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) trial: rationale and design. Am Heart J. 2009;157:488–94.
Leslie K, Myles PS, Chan MTV, et al. Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial. Anesth Analg. 2011;112:387–93.
Delcò F, Tchambaz L, Schlienger R, et al. Dose adjustment in patients with liver disease. Drug Saf. 2005;28:529–45.
Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg. 1993;77:1031–40.
Richardson SP, Egan TD. The safety of remifentanil by bolus injection. Expert Opin Drug Saf. 2005;4:643–51.
Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43:879–923.
Murphy EJ. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care. 2005;33:311–22.
Prescott LF. Paracetamol: past, present, and future. Am J Ther. 2000;7:143–7.
Craig RG, Hunter JM. Neuromuscular blocking drugs and their antagonists in patients with organ disease. Anaesthesia. 2009;64 Suppl 1Suppl 1:55–65.
Curatolo M. Adding regional analgesia to general anaesthesia: increase of risk or improved outcome? Eur J Anaesthesiol. 2010;27:586–91.
Fischer B. Benefits, risks, and best practice in regional anesthesia: do we have the evidence we need? Reg Anesth Pain Med. 2010;35:545–8.
Marret E, Remy C, Bonnet F, Postoperative Pain Forum Group. Meta-analysis of epidural analgesia versus parenteral opioid analgesia after colorectal surgery. Br J Surg. 2007;94:665–73.
Park WY, Thompson JS, Lee KK. Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled veterans affairs cooperative study. Ann Surg. 2001;234:560–9.
Rigg JR, Jamrozik K, Myles PS, MASTER Anaethesia Trial Study Group, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet. 2002;359:1276–82.
Peyton PJ, Myles PS, Silbert BS, et al. Perioperative epidural analgesia and outcome after major abdominal surgery in high-risk patients. Anesth Analg. 2003;96:548–51.
Wijeysundera DN, Beattie WS, Austin PC, et al. Epidural anaesthesia and survival after intermediate-to-high risk non-cardiac surgery: a population-based cohort study. Lancet. 2008;372:562–9.
Exadaktylos AK, Buggy DJ, Moriarty DC, et al. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;4:660–4.
Biki B, Mascha E, Moriarty DC, et al. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology. 2008;109:180–7.
Myles PS, Peyton P, Silbert B, for the ANZCA Trials Group Investigators, et al. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: a randomised trial. BMJ. 2011;342:d1491.
Neal JM, Bernards CM, Hadzic A, et al. ASRA practice advisory on neurologic complications in regional anesthesia and pain medicine. Reg Anesth Pain Med. 2008;33:404–15.
Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (third edition). Reg Anesth Pain Med. 2010;35:64–101.
Horlocker TT, Wedel DJ. Infectious complications of regional anesthesia. Best Pract Res Clin Anaesthesiol. 2008;22:451–75.
Richardson J, Lönnqvist PA, Naja Z. Bilateral thoracic paravertebral block: potential and practice. Br J Anaesth. 2011;106:164–71.
Siddiqui MR, Sajid MS, Uncles DR, et al. A meta-analysis on the clinical effectiveness of transversus abdominis plane block. J Clin Anesth. 2011;23:7–14.
Forastiere E, Sofra M, Giannarelli D, et al. Effectiveness of continuous wound infusion of 0.5 % ropivacaine by On-Q pain relief system for postoperative pain management after open nephrectomy. Br J Anaesth. 2008;101:841–7.
Goodnough LT. Autologous blood donation. Anesthesiol Clin North America. 2005;23:263–70.
Maithel SK, Jarnagin WR. Adjuncts to liver surgery: is acute normovolemic hemodilution useful for major hepatic resections? Adv Surg. 2009;43:259–68.
Pape A, Habler O. Alternatives to allogeneic blood transfusions. Best Pract Res Clin Anaesthesiol. 2007;2:221–39.
Carless PA, Henry DA, Moxey AJ, et al. Cell salvage for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2010(4):CD001888.
Gurusamy KS, Li J, Sharma D, et al. Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database Syst Rev. 2009(4):CD008085.
Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpatient surgery. N Engl J Med. 2009;361:1368–75.
Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.
Devereaux PJ, Chan MTV, Eikelboom J. Major vascular complications in patients undergoing non-cardiac surgery: magnitude of the problem, risk prediction, surveillance, and prevention. In: Yusuf S, Cairns JA, Camm AJ, et al., editors. Evidence based cardiology. 3rd ed. West Sussex: Wiley-Blackwell; 2010. p. 47–62.
Devereaux PJ, Pogue J, Guyatt G, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011;154(8):523–8.
Devereaux PJ, Yang H, Yusuf S, on behalf of POISE Investigators, et al. Effects of metoprolol succinate extended-release in patients undergoing noncardiac surgery: a randomised controlled trial. Lancet. 2008;371:1839–47.
Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–24.
Ginès P, Guevara M, Arroyo V, et al. Hepatorenal syndrome. Lancet. 2003;362:1819–27.
Bamji N, Cohen LB. Endoscopic sedation of patients with chronic liver disease. Clin Liver Dis. 2010;14:185–94.
Williams EJ, Taylor S, Fairclough P, BSG Audit of ERCP, et al. Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice. Gut. 2007;56:821–9.
American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002;96:1004–17.
Heuss LT, Drewe J, Schnieper P, et al. Patient-controlled versus nurse-administered sedation with propofol during colonoscopy. A prospective randomized trial. Am J Gastroenterol. 2004;99:511–8.
Campbell L, Imrie G, Doherty P, et al. Patient maintained sedation for colonoscopy using a target controlled infusion of propofol. Anaesthesia. 2004;59:127–32.
Chen SC, Rex DK. An initial investigation of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy. Am J Gastroenterol. 2004;99:1081–6.
Chui PT, Gin T, Oh TE. Anaesthesia for laparoscopic general surgery. Anaesth Intensive Care. 1993;21:163–71.
Cunningham AJ. Anesthetic implications of laparoscopic surgery. Yale J Biol Med. 1998;71:551–78.
Gerges FJ, Kanazi GE, Jabbour-Khoury SI. Anesthesia for laparoscopy: a review. J Clin Anesth. 2006;18:67–78.
Alkozai EM, Lisman T, Porte RJ. Bleeding in liver surgery: prevention and treatment. Clin Liver Dis. 2009;13:145–54.
Schroeder RA, Kuo PC. Pro: low central venous pressure during liver transplantation—not too low. J Cardiothorac Vasc Anesth. 2008;22:311–4.
Massicotte L, Beaulieu D, Thibeault L. Con: low central venous pressure during liver transplantation. J Cardiothorac Vasc Anesth. 2008;22:315–7.
Kim YK, Chin JH, Kang SJ, et al. Association between central venous pressure and blood loss during hepatic resection in 984 living donors. Acta Anaesthesiol Scand. 2009;53:601–6.
Lau WY, Lai EC, Lau SH. Methods of vascular control technique during liver resection: a comprehensive review. Hepatobiliary Pancreat Dis Int. 2010;9:473–81.
Fu SY, Lau WY, Li AJ, et al. Liver resection under total vascular exclusion with or without preceding Pringle manoeuvre. Br J Surg. 2010;97:50–5.
Chui AK, Island ER, Rao AR, et al. The longest survivor and first potential cure of an advanced cholangiocarcinoma by ex vivo resection and autotransplantation: a case report and review of the literature. Am Surg. 2003;69:441–4.
Fu SY, Lai EC, Li AJ, et al. Liver resection with selective hepatic vascular exclusion: a cohort study. Ann Surg. 2009;249:624–7.
De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl. 2000;6:309–16.
Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451–8.
Ozier Y, Klinck JR. Anesthetic management of hepatic transplantation. Curr Opin Anaesthesiol. 2008;21:391–400.
Della Rocca G, Brondani A, Costa MG. Intraoperative hemodynamic monitoring during organ transplantation: what is new? Curr Opin Organ Transplant. 2009;14:291–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht and People's Medical Publishing House
About this chapter
Cite this chapter
Ho, S.S., Chan, M.T.V. (2013). Anesthesia for Patients with Hilar Chlolangiocarcinoma. In: Lau, W. (eds) Hilar Cholangiocarcinoma. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6473-6_15
Download citation
DOI: https://doi.org/10.1007/978-94-007-6473-6_15
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6472-9
Online ISBN: 978-94-007-6473-6
eBook Packages: MedicineMedicine (R0)